Macromoltek
Macromoltek, based in Austin, TX, specializes in designing custom antibodies using computational modeling for the healthcare industry, particularly in drug discovery and delivery.
Services
Macromoltek offers a range of services in the field of drug discovery and delivery. These services include discovering antibodies for a single target, improving existing antibody structures, solving specific antibody design problems, humanizing therapeutic antibodies, and epitope mapping of antigens. By using computational modeling, Macromoltek can design custom antibodies in as little as one week. This rapid and innovative approach addresses a variety of needs within the healthcare industry.
Proprietary Platform
Macromoltek has developed a proprietary platform that enables the design of antibodies against difficult targets that are typically inaccessible by traditional methods. This sophisticated technology leverages computational modeling to expedite and enhance the antibody design process. As a result, the platform provides valuable solutions for challenging antibody discovery and design problems that other techniques cannot effectively tackle.
Tools and Utilities
Macromoltek provides several tools and utilities to aid in the field of drug discovery and delivery. These include a Codon to Sequence Tool, which converts codon triplets to their respective one-letter amino acid codes, and an Amino Acid Codes utility, which offers a quick reference for various amino acids and their respective code names. These tools are designed to streamline the workflow for researchers and professionals working in antibody design and development.
Company Location and Contact Information
Macromoltek is headquartered in Austin, Texas, at 2500 West William Cannon Dr., Suite 204, Austin, TX 78745. The company can be contacted by phone at +1 (512) 330 - 4948. Macromoltek serves regions within the United States of America and extends its services to America and Canada, focusing on the healthcare industry's drug discovery and delivery sub-sector.
Y-Combinator Involvement
Macromoltek participated in the Winter 2018 (W18) batch of Y Combinator, a prestigious startup accelerator. This involvement has provided Macromoltek with support, networking opportunities, and resources to develop their innovative solutions in healthcare, particularly in the sub-industry of drug discovery and delivery.